NYU Langone's Perlmutter Cancer Center | Strategic Alliance Partners
Latest from NYU Langone's Perlmutter Cancer Center
Ongoing Research to Watch in Ovarian Cancer in 2025
April 03, 2025
Video
Bhavana Pothuri, MD, and Tiffany Redfern, MD, FACOG, discuss ongoing research and areas of potential investigation in ovarian cancer.
Highlighting Key Ovarian Cancer Data from the 2025 SGO Annual Meeting
April 03, 2025
Video
Bhavana Pothuri, MD, and Tiffany Redfern, MD, FACOG, discuss updates in ovarian cancer from the 2025 SGO Annual Meeting.
Exploring Other Potential Roles for Mirvetuximab Soravtansine in Ovarian Cancer
April 03, 2025
Video
Bhavana Pothuri, MD, and Tiffany Redfern, MD, FACOG, discuss other potential roles for mirvetuximab soravtansine in ovarian cancer.
PRO Data for Mirvetuximab Soravtansine From MIRASOL in FRa+ Platinum-Resistant Ovarian Cancer
April 03, 2025
Video
Bhavana Pothuri, MD, and Tiffany Redfern, MD, FACOG, on patient-reported outcome data for mirvetuximab soravtansine in platinum-resistant ovarian cancer.
MIRASOL Trial: Final OS Data for Mirvetuximab Soravtansine in FRa+ Platinum-Resistant Ovarian Cancer
April 03, 2025
Video
Bhavana Pothuri, MD, and Tiffany Redfern, MD, FACOG, on final overall survival data for mirvetuximab soravtansine in platinum-resistant ovarian cancer.
Current Treatment Approaches and Challenges in Platinum-Resistant Ovarian Cancer
March 31, 2025
Video
Bhavana Pothuri, MD, and Tiffany Redfern, MD, FACOG, discuss current treatment approached in platinum-resistant ovarian cancer.
Dr Pothuri on the Current Treatment Paradigm in Endometrial Cancer
February 14, 2025
Video
Bhavana Pothuri, MD, discusses the current treatment paradigm in endometrial cancer and the targeted therapies currently being investigated.
Dr Braunstein on Novel Risk Factors for Veno-Occlusive Disease Development
October 30, 2024
Video
Marc J. Braunstein, MD, PhD, discusses VOD risk factors, management strategies, and prevention strategies in the post-HSCT hematologic malignancy setting.
Oncology Community Mourns the Loss of Dr Jeffrey S. Weber, 2016 Giant of Cancer Care® Winner
August 19, 2024
Article
Jeffrey S. Weber, MD, PhD, inductee of the 2016 Giants of Cancer Care award in Melanoma, has died.
Dr Sabari on Barriers to Biomarker Testing in NSCLC
July 25, 2024
Video
Joshua K. Sabari, MD, discusses barriers to biomarker testing in patients with non–small cell lung cancer.
Dr Pothuri on Real-World Treatment Patterns Per MMR/MSI Status in Endometrial Cancer
June 27, 2024
Video
Bhavana Pothuri, MD, discusses real-world treatment patterns and outcomes in patients with advanced endometrial cancer according to MMR/MSI status.
Dr Krogsgaard on Phosphorylated Neoantigen Targets for Anticancer Vaccine Development
May 22, 2024
Video
Michelle Krogsgaard, PhD, discusses the identification and potentially utility of phosphorylated neoantigen targets for anticancer vaccine development.
Dr Marc Braunstein: Program Building, Education in Hematologic Cancers
April 23, 2024
Video
Marc J. Braunstein, MD, PhD, FACP, of NYU Grossman Long Island School of Medicine, discusses lessons learned with program building and medical education with hematologic cancers.
Dr Sabari on the FDA Approval of Frontline Amivantamab Plus Chemo in EGFR Exon 20 Insertion+ NSCLC
March 29, 2024
Video
Joshua K. Sabari, MD, discusses the FDA approval of frontline amivantamab plus chemotherapy for NSCLC harboring EGFR exon 20 insertion mutations.
First-Line Niraparib Maintenance Is Not Associated With Worse HRQOL in Advanced Ovarian Cancer
March 13, 2024
Article
First-line niraparib maintenance was not associated with worsened health-related quality of life outcomes vs placebo in advanced ovarian cancer.
Durvalumab ± Tremelimumab + Chemotherapy in First-Line Metastatic NSCLC: 5-Year Overall Survival Update from the POSEIDON Study
February 26, 2024
Video
Joshua K. Sabari, MD, reviews data from the 5-year overall survival update from the POSEIDON study investigating durvalumab, tremelimumab, and chemotherapy in first-line metastatic non–small cell lung cancer.
Breaking Boundaries: Advancements and Challenges in Treatment with ADCs in NSCLC
February 15, 2024
Article
Joshua K. Sabari, MD, discusses updates in ADCs in NSCLC.
Unlocking the Potential: The Evolution of ADCs in HER2+ NSCLC
February 14, 2024
Article
Joshua K. Sabari, MD, explains the utility of ADCs in patients with NSCLC and their benefit in patients with EGFR-, ALK-, or HER2-mutant disease.
Dr Sabari on the Potential Role for Patritumab Deruxtecan in NSCLC
February 09, 2024
Video
Joshua K. Sabari, MD, discusses the investigation of patritumab deruxtecan in EGFR-mutant non–small cell lung cancer.
Dr Weber on the Background of the KEYNOTE-942 Trial in High-Risk Melanoma
February 08, 2024
Video
Jeffrey S. Weber, MD, PhD, discusses the background for the KEYNOTE-942 trial, which was conducted in resected high-risk melanoma.